Literature DB >> 13417492

[Mechanism of action of heparin as antithrombin and dynamics of fibrin formation].

R AMANN, E WERLE.   

Abstract

Entities:  

Keywords:  FIBRIN; HEPARIN

Mesh:

Substances:

Year:  1957        PMID: 13417492     DOI: 10.1007/bf01477428

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


× No keyword cloud information.
  10 in total

1.  The action of poly-lysine on the conversion of fibrinogen into fibrin by coagulase thrombin.

Authors:  N BIEZUNSKI; E SHAFRIR; A DE VRIES; E KATCHALSKI
Journal:  Biochem J       Date:  1955-01       Impact factor: 3.857

2.  [Heparin and antithrombin consumption].

Authors:  M BURSTEIN; A GUINAND
Journal:  Arch Int Pharmacodyn Ther       Date:  1956-01-01

3.  Chemistry of prothrombin and some of its reactions.

Authors:  K LAKI
Journal:  Physiol Rev       Date:  1954-10       Impact factor: 37.312

4.  Action of poly-alpha-amino acids on clotting of fibrinogen by thrombin.

Authors:  E SHAFRIR; A DE VRIES; E KATCHALSKI
Journal:  Proc Soc Exp Biol Med       Date:  1954-10

5.  Fibrino-peptide.

Authors:  L LORAND
Journal:  Biochem J       Date:  1952-10       Impact factor: 3.857

6.  The antithrombin activity of heparin.

Authors:  J W LYTTLETON
Journal:  Biochem J       Date:  1954-09       Impact factor: 3.857

7.  The antithrombin activity of human plasma.

Authors:  J W LYTTLETON
Journal:  Biochem J       Date:  1954-09       Impact factor: 3.857

8.  Antithrombin and heparin in human blood.

Authors:  T A LOOMIS
Journal:  J Lab Clin Med       Date:  1949-05

9.  Analysis of the native heparin-lipoprotein complex including the identification of a heparin complement (heparin co-factor) obtained from extracts of tissue mast cells.

Authors:  O SNELLMAN; B SYLVEN; C JULEN
Journal:  Biochim Biophys Acta       Date:  1951-05

10.  The nature of plasma antithrombin activity.

Authors:  P D KLEIN; W H SEEGERS
Journal:  Blood       Date:  1950-08       Impact factor: 22.113

  10 in total
  1 in total

1.  [On the binding of kallidin to heparin].

Authors:  E WERLE; I TRAUTSCHOLD; G LEYSATH
Journal:  Experientia       Date:  1961-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.